EPIPAGE 2 is a French national study focusing on preterm babies.
The project seeks to provide new data on the prognosis and etiology of very preterm birth and to assess related medical practices.
Scientific field(s): Public health and epidemiology, Paediatrics
Data were collected about the pregnancy and delivery focus on specific pregnancy complications, infectious, inflammatory, vascular-placental diseases, medication use up to birth, decisions about termination of pregnancy, delivery and limitations of care.
The neonatal component captures the child's condition at birth, neonatal diseases, organisation of care and management after birth, treatment and medication, and abnormalities in early brain development and maturation assessed by imaging techniques.
Data was also collected on attitudes of care for extremely preterm births (situations where intensive treatment was initiated, pursued, and subsequently limited.
Mothers were interviewed in the neonatal unit to obtain information about the family's social position and the mother's perception of her prenatal management. Each mother also completed a self-administered questionnaire assessing her mental health and the management of her baby in neonatal units.
Maternity and neonatal units were also distributed questionnaires about their structural characteristics, organisation, policies and practices related to medical interventions and decision-making processes.
Follow-up consists in questionnaires sent to families and health check-ups (clinical examination and psychological tests).
Data processing level:
Raw
Method(s): Interviews, Record linkage
Data from medical records were extracted from each maternity and neonatal units and completed by questions to obstetrical and neonatal teams.
Condition(s)/Disease(s): Preterm newborns
Associated ressources:
-
10.1186/1471-2431-14-97: Ancel, P.-Y. & Goffinet, F. EPIPAGE 2: a preterm birth cohort in France in 2011. BMC Pediatr. 14, 97 (2014).
Catalogue record last updated: June 17, 2026, midnight
| Data collectors |
Inserm |
| Data collection period |
2011-now |
| Is data still collected? |
Yes |
| Variable count/number |
ND |
| Sample size (of participants) |
5,600 |
| Geographic coverage (of participants) - Countries
|
France |
| Geographic coverage (of participants) - Regions
|
Europe |
| Age range (of participants) |
Preterm babies born from 22 weeks of amenorrhoea; followed up to 13 years of age. |
| Age range (of participants) - Categories |
Children |
| Family data? |
Yes
|
| Database host |
Inserm |
| Hosting countries |
France |
| Version (of the database) |
ND |
| File format |
ND |
| Database size |
ND |
| Data access |
Restricted Access |
| Data sharing policy |
Data from the Epipage 2 study are available to any public or private research team, whether French or foreign, on the basis of a research project and subject to the conditions specified in the data access charter.
Each request to access the data is reviewed by 2 committees:
- The Scientific Group (epidemiologists, paediatricians and obstetricians who assess the scientific value of the application)
- The Data Access Group (statisticians and data mangers who assess the technical feasibility of proposed analyses, ensure that the processing of the data complies with the CNIL's MR-004 and advises project leaders to obtain the necessary authorisations if this is not the case)
Following approval by the Scientific Group and the Data Access Group, the project leader must sign a letter of commitment before being granted access to the data. |
| Data downloadable? |
Unknown |
| Fees |
ND |
| Usable for commercial purposes? |
ND |
| Access for Pasteur scientists |
https://pasteurfr.sharepoint.com/:b:/s/VieScientifique/IQDQ338tr_aQQoQzufjqTGs6Aeb8fmsZTg9Jerj3RW3f2kA?e=fDP7y8
|